Assignee
PETER MACCALLUM CANCER INST
AU·11 granted patents·13 pending applications·73 citations·filing 2000–2024
Top patents by PatentIndex Score
24 records- 0185US6548505B1RadioprotectorsPETER MACCALLUM CANCER INST·Filed 2000·Granted Apr 15, 2003·47 cites·12 claims
- 0283US6485971B1Keratinocyte stem cellsPETER MACCALLUM CANCER INST·Filed 2000·Granted Nov 26, 2002·24 cites·32 claims
- 0365US7718379B2Identifying haematopoietic stem cells based on cell surface markersPETER MACCALLUM CANCER INST·Filed 2007·Granted May 18, 2010·1 cites·5 claims
- 0464US2026077071A1Targeted Delivery of Theranostic AgentsPETER MACCALLUM CANCER INST·Filed 2023·Application pending·0 cites
- 0562US7718376B2Identification and isolation of somatic stem cells and uses thereofPETER MACCALLUM CANCER INST·Filed 2002·Granted May 18, 2010·1 cites·25 claims
- 0659US2024150482A1Bispecific polypeptides for engagement of car expressing immune cells with antigen presenting cells and uses thereofPETER MACCALLUM CANCER INST·Filed 2023·Application pending·0 cites
- 0759US2025101073A1Modified t cells and uses thereofPETER MACCALLUM CANCER INST·Filed 2024·Application pending·0 cites
- 0855US12202855B2Modified T cells and uses thereofPETER MACCALLUM CANCER INST·Filed 2019·Granted Jan 21, 2025·0 cites·9 claims
- 0955US11866504B2Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereofPETER MACCALLUM CANCER INST·Filed 2019·Granted Jan 9, 2024·0 cites·16 claims
- 1051USRE46943ERadioprotector compounds and methodsPETER MACCALLUM CANCER INST·Filed 2011·Granted Jul 10, 2018·0 cites·20 claims
- 1146US2005003460A1Detection of haematopoietic stem cells and progeny and uses thereofPETER MACCALLUM CANCER INST·Filed 2004·Application pending·0 cites
- 1244US2011190244A1Method of treatment of egfr inhibitor toxicityPETER MACCALLUM CANCER INST·Filed 2010·Application pending·0 cites
- 1344US2025249096A1Compositions and Methods for ImmunotherapyPETER MACCALLUM CANCER INST·Filed 2021·Application pending·0 cites
- 1444US2024360516A1Methods for the analysis of gene expression and uses thereofPETER MACCALLUM CANCER INST·Filed 2022·Application pending·0 cites
- 1543US2011171642A1Analysing Methylation Specific PCR by Amplicon MeltingPETER MACCALLUM CANCER INST·Filed 2009·Application pending·0 cites
- 1642US9862776B2Antibodies against human RYK and uses thereforPETER MACCALLUM CANCER INST·Filed 2014·Granted Jan 9, 2018·0 cites·2 claims
- 1742US2003113913A1Method of enhancing self renewal of stem cells and uses thereofPETER MACCALLUM CANCER INST·Filed 2002·Application pending·0 cites
- 1839US9896443B2Perforin inhibiting benzenesulfonamide compounds, preparation and uses thereofPETER MACCALLUM CANCER INST·Filed 2013·Granted Feb 20, 2018·0 cites·8 claims
- 1939US2011020314A1Identifying haematopoietic stem cells based on cell surface markersPETER MACCALLUM CANCER INST·Filed 2010·Application pending·0 cites
- 2038US2014128450A1Cancer TherapyPETER MACCALLUM CANCER INST·Filed 2013·Application pending·0 cites
- 2134US2010261180A1Recombinant perforin, expression and uses thereofPETER MACCALLUM CANCER INST·Filed 2010·Application pending·0 cites
- 2234US2008160610A1Methods for Stem Cell Expansion and DifferentiationPETER MACCALLUM CANCER INST·Filed 2005·Application pending·0 cites
- 2333US11828759B2Method of diagnosisPETER MACCALLUM CANCER INST·Filed 2017·Granted Nov 28, 2023·0 cites·14 claims
- 2431US9896663B2Leukaemia stem cell line, its method of production and uses thereofPETER MACCALLUM CANCER INST·Filed 2016·Granted Feb 20, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when PETER MACCALLUM CANCER INST files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →